ERBB2 and breast cancer: Triple-negative breast cancer (TNBC), which is characterized by negative expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), accounts for approximately 15% of all breast cancers [1].